Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Research
ARPA-H director eyes future beyond vaccines
Alicia Jackson, Ph.D., thinks new technologies like monoclonal antibodies can help end the vaccine "debate" by rendering vaccines obsolete.
Darren Incorvaia
Jan 20, 2026 5:00am
JPM26: Chugai chases new science and name recognition
Jan 16, 2026 5:28am
JPM26: Gilead eyes new deals from a 'position of strength'
Jan 14, 2026 3:30am
JPM: Novo CSO craves 'different flavors' of pipeline innovation
Jan 13, 2026 7:45am
Takeda leader says AI gave early-stage asset a 'phoenix' rebirth
Jan 13, 2026 6:16am
NIH loses another leader as heart, lung and blood director exits
Jan 13, 2026 4:00am
